Search Within

Michael Joseph Cavnar

  1. "Sarcoma Service"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (2)
Groups
  1. Center for Pancreatic Cancer Research (6)
  2. Department of Medicine (6)
  3. GSK Faculty (6)
  4. Human Oncology and Pathogenesis Program (6)
  5. Sarcoma Service (6)
  6. Solid Tumor Oncology Division (6)

More Groups

People
  1. Ronald DeMatteo (6)
  2. Vinod Balachandran (6)
  3. William Tap (6)
  4. Cristina Antonescu (5)
  5. Samuel Singer (5)
  6. Christina Curtin (3)

More People

Years
  1. 2021 (2)
  2. 2019 (1)
  3. 2017 (1)
  4. 2016 (1)
  5. 2013 (1)
Publications
  1. Annals of Surgical Oncology (3)
  2. Annals of Surgery (1)
  3. Journal of Gastrointestinal Surgery (1)
  4. Journal of the American College of Surgeons (1)
Publishers
  1. Springer (4)
  2. Elsevier Science, Inc. (1)
  3. Lippincott Williams & Wilkins (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic factors after neoadjuvant imatinib for newly diagnosed primary gastrointestinal stromal tumor
    Journal Article

    Cavnar, M. J.; Seier, K.; Gönen, M.; Curtin, C.; Balachandran, V. P.; Tap, W. D.; Antonescu, C. R.; Singer, S.; DeMatteo, R. P.
    Journal of Gastrointestinal Surgery (2021)

    Fulltext@MSK | Save
  • Outcome of 1000 patients with gastrointestinal stromal tumor (GIST) treated by surgery in the pre- and post-imatinib eras
    Journal Article

    Cavnar, M. J.; Seier, K.; Curtin, C.; Balachandran, V. P.; Coit, D. G.; Yoon, S. S.; Crago, A. M.; Strong, V. E.; Tap, W. D.; Gönen, M.; more...
    Annals of Surgery (2021)

    Fulltext@MSK | Save
  • Tumor mitotic rate after neoadjuvant imatinib is associated with outcome in primary gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Cavnar, M. J.; Seier, K.; Mithat, G.; Balachandran, V. P.; Curtin, C.; Keohan, M.; Tap, W.; Antonescu, C.; Singer, S.; DeMatteo, R. P.
    Annals of Surgical Oncology (2019)

    Fulltext@MSK | Save
  • Rectal gastrointestinal stromal tumor (GIST) in the era of imatinib: Organ preservation and improved oncologic outcome
    Journal Article

    Cavnar, M. J.; Wang, L.; Balachandran, V. P.; Antonescu, C. R.; Tap, W. D.; Keohan, M.; Singer, S.; Temple, L.; Nash, G. M.; Weiser, M. R.; more...
    Annals of Surgical Oncology (2017)

    Fulltext@MSK | Save
  • Chronic imatinib (> 3 years) therapy after complete resection of primary, high-risk gastrointestinal stromal tumor (GIST) is associated with low recurrence
    Meeting Abstract

    Cavnar, M. J.; Balachandran, V. P.; Chi, P.; Keohan, M. L.; Tap, W. D.; DeMatteo, R. P.
    Journal of the American College of Surgeons (2016)

    Fulltext@MSK | Save
  • Blood neutrophil-to-lymphocyte ratio is prognostic in gastrointestinal stromal tumor
    Journal Article

    Perez, D. R.; Baser, R. E.; Cavnar, M. J.; Balachandran, V. P.; Antonescu, C. R.; Tap, W. D.; Strong, V. E.; Brennan, M. F.; Coit, D. G.; Singer, S.; more...
    Annals of Surgical Oncology (2013)

    Fulltext@MSK | Save